1. Catalog
  2. Homozygous Familial Hypercholesterolemia: Preventi ...
Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment
(2)
Availability
No future session
Expires on Oct 03, 2026
Cost
$0.00
Credit Offered
1 CME Credit
1 Nursing Credit
1 ABIM-MOC Point
  • Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment.
  • Learning Objectives
  • Faculty
  • Recommended

AACE Rare Diseases and Hormone Disorders Webinar Series is pleased to present Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment. This webinar is designed to help clinicians create a path to diagnosis when encountering a patient with Homozygous Familial Hypercholesterolemia (HoFH). 

 

This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest evidence-based clinical guidance and educational resources for diagnosing, managing, and treating HoFH. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease. 

Please Login to register for this webinar. 

Upon completion of the program, participants will be able to:

1. Describe the diagnostic and testing approach in evaluating a patient with homozygous familial hypercholesterolemia.

 

2. Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat homozygous familial hypercholesterolemia.

 

3. Identify and treat long-term complications and comorbidities of homozygous familial hypercholesterolemia.


Eliot Brinton, MD, FAHA, FNLA, FACE
Past President, American Board of Clinical Lipidology
President, Utah Lipid Center
Salt Lake City, Utah



Lance Sloan, MD, MSE, FACE, FASN, FACP, FEAA, FASPC
Medical Director
Texas Institute for Kidney and Endocrine Disorders
Lufkin, TX

Android App Download IOS App Download Powered By